LAMPIT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is Nifurtimox.
| Product ID | 50419-751_06512bbe-ca2d-436b-92d0-447aff049c3b |
| NDC | 50419-751 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LAMPIT |
| Generic Name | Nifurtimox |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-10-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA213464 |
| Labeler Name | Bayer Healthcare Pharmaceuticals INC. |
| Substance Name | NIFURTIMOX |
| Active Ingredient Strength | 120 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-10-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50419-750 | LAMPIT | nifurtimox |
| 50419-751 | LAMPIT | nifurtimox |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LAMPIT 86226905 4702596 Live/Registered |
Bayer Intellectual Property GmbH 2014-03-20 |